Dr Claudia Geue

  • Senior Lecturer in Health Economics and Health Technology Assessment (Health Economics & Health Technology Assessment)

telephone: 0141 330 3294
email: Claudia.Geue@glasgow.ac.uk

HEHTA, 1 Clarice Pears Building, School of Health & Wellbeing, 90 Byres Road, Glasgow, G12 8TB

Import to contacts

ORCID iDhttps://orcid.org/0000-0003-2243-0733

Biography

Claudia is a senior lecturer in Health Economics and Health Technology Assessment at the University of Glasgow. She holds a degree in Economics (2004) from The University of Potsdam, Germany and a PhD in Health Economics (2012) from the University of Glasgow, Scotland. Prior to joining HEHTA in 2008, she has worked as a research assistant at HERU, University of Aberdeen.

Research interests

Claudia’s research interests are in the area of data science and the use of real-world evidence in health- and social care decision making. Her research focuses on analysing routinely collected health and social care data to answer research questions of socio-economic and geographical patterning of health- and social care utilisation and related expenditure. Her PhD and post-doctoral fellowship analysed the association between remaining life time and healthcare expenditure. She has also been involved in a large number of projects evaluating the impact of public health interventions. Claudia’s research interests are both, methodological and applied. Claudia is Co-Lead of the MSc in Health Economics and HTA and the academic lead for ‘Real World Data in Healthcare Decision Making’. She supervises PhD, MSc and MPH students at the University of Glasgow.

 

Publications

List by: Type | Date

Jump to: 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009
Number of items: 50.

2024

Sosenko, F. et al. (2024) Cancer diagnosis after emergency presentation: impact of demographics, cancer types, and pandemic. Academia Oncology, 1(2), pp. 1-8. (doi: 10.20935/AcadOnco7422)

Mulholland, R. J. , Ciminata, G., Quinn, T. J. , Pollock, K. G., Lister, S. and Geue, C. (2024) Delay and pay? Healthcare costs associated with late oral anti-coagulant prescribing in people with atrial fibrillation. PharmacoEconomics, 42(11), pp. 1241-1253. (doi: 10.1007/s40273-024-01419-2) (PMID:39093500) (PMCID:PMC11499361)

MacRae, J., Ciminata, G., Geue, C. , Lynch, E., Shenkin, S. D., Quinn, T. J. and Burton, J. K. (2024) Mortality among long-term care residents: a retrospective cohort study. BMJ Supportive and Palliative Care, (doi: 10.1136/spcare-2024-005163) (PMID:39384193) (Early Online Publication)

Putri, S. , Ciminata, G., Lewsey, J. , Jani, B. , McMeekin, N. and Geue, C. (2024) The conceptualisation of cardiometabolic disease policy model in the UK. BMC Health Services Research, 24, 1060. (doi: 10.1186/s12913-024-11559-y) (PMID:39272116)

Ciminata, G., Burton, J.K. , Quinn, T.J. and Geue, C. (2024) Understanding Pathways into Care-homes using Data (UnPiCD study): a two-part model to estimate inpatient and care-home costs using national linked health and social care data. BMC Health Services Research, 24, 281. (doi: 10.1186/s12913-024-10675-z) (PMID:38443919) (PMCID:PMC10916167)

Mulholland, R.J. , Manca, F., Ciminata, G., Quinn, T.J. , Trotter, R., Pollock, K.G., Lister, S. and Geue, C. (2024) Evaluating the effect of inequalities in oral anti-coagulant prescribing on outcomes in people with atrial fibrillation. European Heart Journal Open, 4(2), oeae016. (doi: 10.1093/ehjopen/oeae016) (PMID:38572087) (PMCID:PMC10989660)

2023

Lim, M. Y., Kamaruzaman, H. F., Wu, O. and Geue, C. (2023) Health financing challenges in Southeast Asian countries for universal health coverage: a systematic review. Archives of Public Health, 81(1), 148. (doi: 10.1186/s13690-023-01159-3) (PMID:37592326) (PMCID:PMC10433621)

Owusu Achiaw, S. , Geue, C. and Grieve, E. (2023) The Role of Universal Health Coverage in Secondary Prevention: A Case Study of Ghana’s National Health Insurance and Early-Onset Hypertension. Diversity in Health Economics, 15th International Health Economics Association World Congress, Cape Town, South Africa, 08-12 Jul 2023.

Kumluang, S., Wu, O. , Langhorne, P. and Geue, C. (2023) Stroke resource utilisation and all-cause mortality in Thailand 2017–2020: a retrospective, cross-sectional study. BMJ Open, 13(6), e072259. (doi: 10.1136/bmjopen-2023-072259) (PMID:37280024) (PMCID:PMC10255610)

2022

Kumluang, S., Geue, C. , Langhorne, P. and Wu, O. (2022) Availability of stroke services and hospital facilities at different hospital levels in Thailand: a cross-sectional survey study. BMC Health Services Research, 22, 1558. (doi: 10.1186/s12913-022-08922-2) (PMID:36539806) (PMCID:PMC9764597)

Burton, J. K. , Ciminata, G., Lynch, E., Shenkin, S. D., Geue, C. and Quinn, T. J. (2022) Understanding Pathways into Care homes using Data (UnPiCD study): a retrospective cohort study using national linked health and social care data. Age and Ageing, 51(12), afac304. (doi: 10.1093/ageing/afac304) (PMID:36580557) (PMCID:PMC9799248)

Byrne, A., Chouliara, N., Cameron, T., Geue, C. , Lewis, S., Robinson, T., Langhorne, P. , Walker, M. F. and Fisher, R. J. (2022) Evaluating stroke early supported discharge using cost-consequence analysis. Disability and Rehabilitation, 44(23), pp. 7127-7133. (doi: 10.1080/09638288.2021.1983043) (PMID:34618617)

Rana, D. et al. (2022) Healthcare costs for metastatic castration-resistant prostate cancer patients treated with Abiraterone or Enzalutamide. PharmacoEconomics - Open, 6(2), pp. 303-313. (doi: 10.1007/s41669-021-00307-1) (PMID:34761368)

Ciminata, G., Geue, C. , Wu, O. , Deidda, M. , Kreif, N. and Langhorne, P. (2022) Propensity score methods for comparative-effectiveness analysis: a case study of direct oral anticoagulants in the atrial fibrillation population. PLoS ONE, 17(1), e0262293. (doi: 10.1371/journal.pone.0262293) (PMID:35073380) (PMCID:PMC8786176)

Hsieh, P. H., Geue, C. , Wu, O. , McIntosh, E. and Siebert, S. (2022) How do multiple long-term conditions impact on the cost-of-illness in early rheumatoid arthritis? RMD Open, 8, e002454. (doi: 10.1136/rmdopen-2022-002454) (PMID:36104116) (PMCID:PMC9476122)

2021

Fisher, R. J. et al. (2021) Large-scale implementation of stroke early supported discharge: the WISE realist mixed-methods study. Health Services and Delivery Research, 9(22), (doi: 10.3310/hsdr09220)

Quin, T. J. et al. (2021) Correction to: Following the science? Comparison of methodological and reporting quality of covid-19 and other research from the first wave of the pandemic. BMC Medicine, 19, 207. (doi: 10.1186/s12916-021-02073-7) (PMID:34419019) (PMCID:PMC8380187)

Jonuscheit, S., Geue, C. , Laidlaw, R., Fishbacher, C., Melia, B., Lewsey, J. and King, C. (2021) Towards transforming community eye care: an observational study and time-series analysis of optometrists' prescribing for eye disorders. Public Health, 196, pp. 107-113. (doi: 10.1016/j.puhe.2021.04.029) (PMID:34182255)

Quinn, T. J. et al. (2021) Following the Science? Comparison of methodological and reporting quality of covid-19 and other research from the first wave of the pandemic. BMC Medicine, 19, 46. (doi: 10.1186/s12916-021-01920-x) (PMID:33618741) (PMCID:PMC7899793)

2020

Bouttell, J. , Gonzalez, N., Geue, C. , Lightbody, C. J. and Taylor, D. R. (2020) Cost impact of introducing a treatment escalation/limitation plan during patients’ last hospital admission before death. International Journal for Quality in Health Care, 32(10), pp. 694-700. (doi: 10.1093/intqhc/mzaa132) (PMID:33210722)

McMeekin, P., Geue, C. , Mocevic, E., Hoxer, C.S., Ochs, A., McGurnaghan, S., Colhoun, H.M., Wild, S.H. and Wu, O. (2020) The cost of prevalent and incident cardiovascular disease in people with type 2 diabetes in Scotland: Data from the Scottish Care Information - Diabetes Collaboration (SCI-Diabetes). Diabetic Medicine, 37(11), pp. 1927-1934. (doi: 10.1111/dme.14253) (PMID:31989661)

Rana, D. et al. (2020) Healthcare Costs for Metastatic Castration Resistant Prostate Cancer Patients Treated with Abiraterone or Enzalutamide in the Pre and Post Chemotherapy Setting. EUHEA 2020, Online, 9 July 2020.

Hsieh, P.-H., Wu, O. , Geue, C. , McIntosh, E. , McInnes, I. B. and Siebert, S. (2020) The economic burden of rheumatoid arthritis: a systematic review of literature in biologic era. Annals of the Rheumatic Diseases, 79(6), pp. 771-777. (doi: 10.1136/annrheumdis-2019-216243) (PMID:32245893)

Ciminata, G., Geue, C. , Langhorne, P. and Wu, O. (2020) A two-part model to estimate inpatient, outpatient, prescribing and care home costs associated with atrial fibrillation in Scotland. BMJ Open, 10(3), e028575. (doi: 10.1136/bmjopen-2018-028575) (PMID:32193256)

McMeekin, N., Geue, C. , Briggs, A. , Rombach, I., Li, H. K., Bejon, P., McNally, M., Atkins, B. L., Ferguson, J. and Scarborough, M. (2020) Cost-effectiveness of oral versus intravenous antibiotics (OVIVA) in patients with bone and joint infection: evidence from a non-inferiority trial. Wellcome Open Research, 4, 108. (doi: 10.12688/wellcomeopenres.15314.4)

2019

Scarborough, M. et al. (2019) Oral versus intravenous antibiotics for bone and joint infections: the OVIVA non-inferiority RCT. Health Technology Assessment, 23(38), (doi: 10.3310/hta23380)

Fisher, R. et al. (2019) What is the impact of large-scale implementation of stroke Early Supported Discharge? A mixed methods realist evaluation study protocol. Implementation Science, 14, 61. (doi: 10.1186/s13012-019-0908-0) (PMID:31196123) (PMCID:PMC6567399)

Faray Adeline, N. J., Geue, C. and Hemami, M. R. (2019) Cost-effectiveness of treating hepatitis C in Seychelles. Pan African Medical Journal, 33, 26. (doi: 10.11604/pamj.2019.33.26.17742)

Li, H.-K. et al. (2019) Oral versus intravenous antibiotics for bone and joint infection. New England Journal of Medicine, 380(5), pp. 425-436. (doi: 10.1056/NEJMoa1710926) (PMID:30699315)

Deidda, M. , Geue, C. , Krief, N., Dundas, R. and McIntosh, E. (2019) A framework for conducting economic evaluations alongside natural experiments. Social Science and Medicine, 220, pp. 353-361. (doi: 10.1016/j.socscimed.2018.11.032) (PMID:30513485) (PMCID:PMC6323352)

2018

Sangroongruangsri, S. et al. (2018) Real-world safety of intravitreal bevacizumab and ranibizumab treatments for retinal diseases in Thailand: a prospective observational study. Clinical Drug Investigation, 38(9), pp. 853-865. (doi: 10.1007/s40261-018-0678-5) (PMID:30069864) (PMCID:PMC6153972)

Johnson, M. J., McSkimming, P., McConnachie, A. , Geue, C. , Millerick, Y., Briggs, A. and Hogg, K. (2018) The feasibility of a randomised-controlled trial to compare the cost-effectiveness of palliative cardiology or usual care in people with advanced heart failure: two exploratory prospective cohorts. Palliative Medicine, 32(6), pp. 1133-1141. (doi: 10.1177/0269216318763225) (PMID:29688127) (PMCID:PMC5967038)

2017

Scarborough, M. et al. (2017) Oral versus intravenous antibiotics for the treatment of bone and joint infection (OVIVA): a multicentre randomised controlled trial. 36th Annual Meeting of the European Bone and Joint Infection Society, Nantes, France, 7-9 Sep 2017.

Claes, J. et al. (2017) PATHway I: design and rationale for the investigation of the feasibility, clinical effectiveness and cost-effectiveness of a technology-enabled cardiac rehabilitation platform. BMJ Open, 7(6), e016781. (doi: 10.1136/bmjopen-2017-016781) (PMID:28667228) (PMCID:PMC5726129)

Geue, C. and Jonuscheit, S. (2017) Effect of individual-level and socioeconomic factors on long-term survival after cataract surgery over a 30-year period. Journal of Cataract and Refractive Surgery, 43(4), pp. 537-542. (doi: 10.1016/j.jcrs.2017.01.018) (PMID:28532940)

2016

Bouttell, J. , Lewsey, J. , Geue, C. , Antony, G., Briggs, A. , McCartney, G., Hutchinson, S., Graham, L. and Heydtmann, M. (2016) The SCottish alcoholic liver disease evaluation: a population-level matched cohort study of hospital-based costs, 1991-2011. PLoS ONE, 11(10), e0162980. (doi: 10.1371/journal.pone.0162980) (PMID:27783619) (PMCID:PMC5082635)

Geue, C. , Wu, O. , Leyland, A. , Lewsey, J. and Quinn, T. J. (2016) Geographic variation of inpatient care costs at the end of life. Age and Ageing, 45(3), pp. 376-381. (doi: 10.1093/ageing/afw040) (PMID:27025763) (PMCID:PMC4846794)

Geue, C. , Lewsey, J. D. , MacKay, D. F. , Antony, G., Fischbacher, C. M., Muirie, J. and McCartney, G. (2016) Scottish keep well health check programme an interrupted time series analysis. Journal of Epidemiology and Community Health, 70(9), pp. 924-929. (doi: 10.1136/jech-2015-206926) (PMID:27072868) (PMCID:PMC5013158)

2015

Geue, C. , Wu, O. , Xin, Y. , Heggie, R., Hutchinson, S., Martin, N. K., Fenwick, E. and Goldberg, D. (2015) Cost-effectiveness of HBV and HCV screening strategies – a systematic review of existing modelling techniques. PLoS ONE, 10(12), e0145022. (doi: 10.1371/journal.pone.0145022) (PMID:26689908) (PMCID:PMC4686364)

Geue, C. , Lorgelly, P., Lewsey, J. , Hart, C. and Briggs, A. (2015) Hospital expenditure at the end-of-life: what are the impacts of health status and health risks? PLoS ONE, 10(3), e0119035. (doi: 10.1371/journal.pone.0119035) (PMID:25746728) (PMCID:PMC4352086)

2014

Robinson, M., Geue, C. , Lewsey, J. , Mackay, D. , McCartney, G., Curnock, E. and Beeston, C. (2014) Evaluating the impact of the Alcohol Act on off-trade alcohol sales: a natural experiment in Scotland. Addiction, 109(12), pp. 2035-2043. (doi: 10.1111/add.12701)

Geue, C. , Briggs, A. , Lewsey, J. and Lorgelly, P. (2014) Population ageing and healthcare expenditure projections: new evidence from a time to death approach. European Journal of Health Economics, 15(5), pp. 885-896. (doi: 10.1007/s10198-013-0543-7)

2013

Robinson, M., Geue, C. , Lewsey, J., Mackay, D. , McCartney, G., Curnock, E. and Beeston, C. (2013) Investigation of the effect of a multi-buy discount ban on off-trade alcohol sales: a natural experiment in Scotland. Lancet, 382(Sup3), S17. (doi: 10.1016/S0140-6736(13)62442-3)

Robinson, M., Geue, C. , Lewsey, J. , Mackay, D. , McCartney, G., Curnock, E. and Beeston, C. (2013) Monitoring and Evaluating Scotland’s Alcohol Strategy: The Impact of the Alcohol Act on Off-Trade Alcohol Sales in Scotland. Project Report. NHS Health Scotland, Edinburgh, UK.

van de Luijtgaarden, M. W. M. et al. (2013) Global differences in dialysis modality mix: the role of patient characteristics, macroeconomics and renal service indicators. Nephrology Dialysis Transplantation, 28(5), pp. 1264-1275. (doi: 10.1093/ndt/gft053)

2012

Kramer, A., Stel, V.S., Caskey, F.J., Stengel, B., Elliott, R.F., Covic, A., Geue, C. , Cusumano, A., MacLeod, A.M. and Jager, K.J. (2012) Exploring the association between macroeconomic indicators and dialysis mortality. Clinical Journal of the American Society of Nephrology, (doi: 10.2215/CJN.10461011)

Geue, C. , Lewsey, J. , Lorgelly, P., Govan, L. , Hart, C. and Briggs, A. (2012) Spoilt for choice: implications of costing hospital episode statistics. Health Economics, 21(10), pp. 1201-1216. (doi: 10.1002/hec.1785)

2011

Caskey, F.J. et al. (2011) Global variation in renal replacement therapy for end-stage renal disease. Nephrology Dialysis Transplantation, 26(8), pp. 2604-2610. (doi: 10.1093/ndt/gfq781)

2010

Caskey, F.J., Stel, V.S., Elliott, R.F., Jager, K.J., Covic, A., Cusumano, A., Geue, C. , Kramer, A., Stengel, B. and MacLeod, A.M. (2010) The EVEREST study: an international collaboration. NDT Plus, 3(1), pp. 28-36. (doi: 10.1093/ndtplus/sfp146)

2009

Geue, C. , Skåtun, D. and Sutton, M. (2009) Economic influences on GP's decisions to provide out-of-hours care. British Journal of General Practice, 59(558), e1-e7. (doi: 10.3399/bjgp09X394806)

This list was generated on Fri Dec 20 20:04:02 2024 GMT.
Jump to: Articles | Research Reports or Papers | Conference or Workshop Item
Number of items: 50.

Articles

Sosenko, F. et al. (2024) Cancer diagnosis after emergency presentation: impact of demographics, cancer types, and pandemic. Academia Oncology, 1(2), pp. 1-8. (doi: 10.20935/AcadOnco7422)

Mulholland, R. J. , Ciminata, G., Quinn, T. J. , Pollock, K. G., Lister, S. and Geue, C. (2024) Delay and pay? Healthcare costs associated with late oral anti-coagulant prescribing in people with atrial fibrillation. PharmacoEconomics, 42(11), pp. 1241-1253. (doi: 10.1007/s40273-024-01419-2) (PMID:39093500) (PMCID:PMC11499361)

MacRae, J., Ciminata, G., Geue, C. , Lynch, E., Shenkin, S. D., Quinn, T. J. and Burton, J. K. (2024) Mortality among long-term care residents: a retrospective cohort study. BMJ Supportive and Palliative Care, (doi: 10.1136/spcare-2024-005163) (PMID:39384193) (Early Online Publication)

Putri, S. , Ciminata, G., Lewsey, J. , Jani, B. , McMeekin, N. and Geue, C. (2024) The conceptualisation of cardiometabolic disease policy model in the UK. BMC Health Services Research, 24, 1060. (doi: 10.1186/s12913-024-11559-y) (PMID:39272116)

Ciminata, G., Burton, J.K. , Quinn, T.J. and Geue, C. (2024) Understanding Pathways into Care-homes using Data (UnPiCD study): a two-part model to estimate inpatient and care-home costs using national linked health and social care data. BMC Health Services Research, 24, 281. (doi: 10.1186/s12913-024-10675-z) (PMID:38443919) (PMCID:PMC10916167)

Mulholland, R.J. , Manca, F., Ciminata, G., Quinn, T.J. , Trotter, R., Pollock, K.G., Lister, S. and Geue, C. (2024) Evaluating the effect of inequalities in oral anti-coagulant prescribing on outcomes in people with atrial fibrillation. European Heart Journal Open, 4(2), oeae016. (doi: 10.1093/ehjopen/oeae016) (PMID:38572087) (PMCID:PMC10989660)

Lim, M. Y., Kamaruzaman, H. F., Wu, O. and Geue, C. (2023) Health financing challenges in Southeast Asian countries for universal health coverage: a systematic review. Archives of Public Health, 81(1), 148. (doi: 10.1186/s13690-023-01159-3) (PMID:37592326) (PMCID:PMC10433621)

Kumluang, S., Wu, O. , Langhorne, P. and Geue, C. (2023) Stroke resource utilisation and all-cause mortality in Thailand 2017–2020: a retrospective, cross-sectional study. BMJ Open, 13(6), e072259. (doi: 10.1136/bmjopen-2023-072259) (PMID:37280024) (PMCID:PMC10255610)

Kumluang, S., Geue, C. , Langhorne, P. and Wu, O. (2022) Availability of stroke services and hospital facilities at different hospital levels in Thailand: a cross-sectional survey study. BMC Health Services Research, 22, 1558. (doi: 10.1186/s12913-022-08922-2) (PMID:36539806) (PMCID:PMC9764597)

Burton, J. K. , Ciminata, G., Lynch, E., Shenkin, S. D., Geue, C. and Quinn, T. J. (2022) Understanding Pathways into Care homes using Data (UnPiCD study): a retrospective cohort study using national linked health and social care data. Age and Ageing, 51(12), afac304. (doi: 10.1093/ageing/afac304) (PMID:36580557) (PMCID:PMC9799248)

Byrne, A., Chouliara, N., Cameron, T., Geue, C. , Lewis, S., Robinson, T., Langhorne, P. , Walker, M. F. and Fisher, R. J. (2022) Evaluating stroke early supported discharge using cost-consequence analysis. Disability and Rehabilitation, 44(23), pp. 7127-7133. (doi: 10.1080/09638288.2021.1983043) (PMID:34618617)

Rana, D. et al. (2022) Healthcare costs for metastatic castration-resistant prostate cancer patients treated with Abiraterone or Enzalutamide. PharmacoEconomics - Open, 6(2), pp. 303-313. (doi: 10.1007/s41669-021-00307-1) (PMID:34761368)

Ciminata, G., Geue, C. , Wu, O. , Deidda, M. , Kreif, N. and Langhorne, P. (2022) Propensity score methods for comparative-effectiveness analysis: a case study of direct oral anticoagulants in the atrial fibrillation population. PLoS ONE, 17(1), e0262293. (doi: 10.1371/journal.pone.0262293) (PMID:35073380) (PMCID:PMC8786176)

Hsieh, P. H., Geue, C. , Wu, O. , McIntosh, E. and Siebert, S. (2022) How do multiple long-term conditions impact on the cost-of-illness in early rheumatoid arthritis? RMD Open, 8, e002454. (doi: 10.1136/rmdopen-2022-002454) (PMID:36104116) (PMCID:PMC9476122)

Fisher, R. J. et al. (2021) Large-scale implementation of stroke early supported discharge: the WISE realist mixed-methods study. Health Services and Delivery Research, 9(22), (doi: 10.3310/hsdr09220)

Quin, T. J. et al. (2021) Correction to: Following the science? Comparison of methodological and reporting quality of covid-19 and other research from the first wave of the pandemic. BMC Medicine, 19, 207. (doi: 10.1186/s12916-021-02073-7) (PMID:34419019) (PMCID:PMC8380187)

Jonuscheit, S., Geue, C. , Laidlaw, R., Fishbacher, C., Melia, B., Lewsey, J. and King, C. (2021) Towards transforming community eye care: an observational study and time-series analysis of optometrists' prescribing for eye disorders. Public Health, 196, pp. 107-113. (doi: 10.1016/j.puhe.2021.04.029) (PMID:34182255)

Quinn, T. J. et al. (2021) Following the Science? Comparison of methodological and reporting quality of covid-19 and other research from the first wave of the pandemic. BMC Medicine, 19, 46. (doi: 10.1186/s12916-021-01920-x) (PMID:33618741) (PMCID:PMC7899793)

Bouttell, J. , Gonzalez, N., Geue, C. , Lightbody, C. J. and Taylor, D. R. (2020) Cost impact of introducing a treatment escalation/limitation plan during patients’ last hospital admission before death. International Journal for Quality in Health Care, 32(10), pp. 694-700. (doi: 10.1093/intqhc/mzaa132) (PMID:33210722)

McMeekin, P., Geue, C. , Mocevic, E., Hoxer, C.S., Ochs, A., McGurnaghan, S., Colhoun, H.M., Wild, S.H. and Wu, O. (2020) The cost of prevalent and incident cardiovascular disease in people with type 2 diabetes in Scotland: Data from the Scottish Care Information - Diabetes Collaboration (SCI-Diabetes). Diabetic Medicine, 37(11), pp. 1927-1934. (doi: 10.1111/dme.14253) (PMID:31989661)

Hsieh, P.-H., Wu, O. , Geue, C. , McIntosh, E. , McInnes, I. B. and Siebert, S. (2020) The economic burden of rheumatoid arthritis: a systematic review of literature in biologic era. Annals of the Rheumatic Diseases, 79(6), pp. 771-777. (doi: 10.1136/annrheumdis-2019-216243) (PMID:32245893)

Ciminata, G., Geue, C. , Langhorne, P. and Wu, O. (2020) A two-part model to estimate inpatient, outpatient, prescribing and care home costs associated with atrial fibrillation in Scotland. BMJ Open, 10(3), e028575. (doi: 10.1136/bmjopen-2018-028575) (PMID:32193256)

McMeekin, N., Geue, C. , Briggs, A. , Rombach, I., Li, H. K., Bejon, P., McNally, M., Atkins, B. L., Ferguson, J. and Scarborough, M. (2020) Cost-effectiveness of oral versus intravenous antibiotics (OVIVA) in patients with bone and joint infection: evidence from a non-inferiority trial. Wellcome Open Research, 4, 108. (doi: 10.12688/wellcomeopenres.15314.4)

Scarborough, M. et al. (2019) Oral versus intravenous antibiotics for bone and joint infections: the OVIVA non-inferiority RCT. Health Technology Assessment, 23(38), (doi: 10.3310/hta23380)

Fisher, R. et al. (2019) What is the impact of large-scale implementation of stroke Early Supported Discharge? A mixed methods realist evaluation study protocol. Implementation Science, 14, 61. (doi: 10.1186/s13012-019-0908-0) (PMID:31196123) (PMCID:PMC6567399)

Faray Adeline, N. J., Geue, C. and Hemami, M. R. (2019) Cost-effectiveness of treating hepatitis C in Seychelles. Pan African Medical Journal, 33, 26. (doi: 10.11604/pamj.2019.33.26.17742)

Li, H.-K. et al. (2019) Oral versus intravenous antibiotics for bone and joint infection. New England Journal of Medicine, 380(5), pp. 425-436. (doi: 10.1056/NEJMoa1710926) (PMID:30699315)

Deidda, M. , Geue, C. , Krief, N., Dundas, R. and McIntosh, E. (2019) A framework for conducting economic evaluations alongside natural experiments. Social Science and Medicine, 220, pp. 353-361. (doi: 10.1016/j.socscimed.2018.11.032) (PMID:30513485) (PMCID:PMC6323352)

Sangroongruangsri, S. et al. (2018) Real-world safety of intravitreal bevacizumab and ranibizumab treatments for retinal diseases in Thailand: a prospective observational study. Clinical Drug Investigation, 38(9), pp. 853-865. (doi: 10.1007/s40261-018-0678-5) (PMID:30069864) (PMCID:PMC6153972)

Johnson, M. J., McSkimming, P., McConnachie, A. , Geue, C. , Millerick, Y., Briggs, A. and Hogg, K. (2018) The feasibility of a randomised-controlled trial to compare the cost-effectiveness of palliative cardiology or usual care in people with advanced heart failure: two exploratory prospective cohorts. Palliative Medicine, 32(6), pp. 1133-1141. (doi: 10.1177/0269216318763225) (PMID:29688127) (PMCID:PMC5967038)

Claes, J. et al. (2017) PATHway I: design and rationale for the investigation of the feasibility, clinical effectiveness and cost-effectiveness of a technology-enabled cardiac rehabilitation platform. BMJ Open, 7(6), e016781. (doi: 10.1136/bmjopen-2017-016781) (PMID:28667228) (PMCID:PMC5726129)

Geue, C. and Jonuscheit, S. (2017) Effect of individual-level and socioeconomic factors on long-term survival after cataract surgery over a 30-year period. Journal of Cataract and Refractive Surgery, 43(4), pp. 537-542. (doi: 10.1016/j.jcrs.2017.01.018) (PMID:28532940)

Bouttell, J. , Lewsey, J. , Geue, C. , Antony, G., Briggs, A. , McCartney, G., Hutchinson, S., Graham, L. and Heydtmann, M. (2016) The SCottish alcoholic liver disease evaluation: a population-level matched cohort study of hospital-based costs, 1991-2011. PLoS ONE, 11(10), e0162980. (doi: 10.1371/journal.pone.0162980) (PMID:27783619) (PMCID:PMC5082635)

Geue, C. , Wu, O. , Leyland, A. , Lewsey, J. and Quinn, T. J. (2016) Geographic variation of inpatient care costs at the end of life. Age and Ageing, 45(3), pp. 376-381. (doi: 10.1093/ageing/afw040) (PMID:27025763) (PMCID:PMC4846794)

Geue, C. , Lewsey, J. D. , MacKay, D. F. , Antony, G., Fischbacher, C. M., Muirie, J. and McCartney, G. (2016) Scottish keep well health check programme an interrupted time series analysis. Journal of Epidemiology and Community Health, 70(9), pp. 924-929. (doi: 10.1136/jech-2015-206926) (PMID:27072868) (PMCID:PMC5013158)

Geue, C. , Wu, O. , Xin, Y. , Heggie, R., Hutchinson, S., Martin, N. K., Fenwick, E. and Goldberg, D. (2015) Cost-effectiveness of HBV and HCV screening strategies – a systematic review of existing modelling techniques. PLoS ONE, 10(12), e0145022. (doi: 10.1371/journal.pone.0145022) (PMID:26689908) (PMCID:PMC4686364)

Geue, C. , Lorgelly, P., Lewsey, J. , Hart, C. and Briggs, A. (2015) Hospital expenditure at the end-of-life: what are the impacts of health status and health risks? PLoS ONE, 10(3), e0119035. (doi: 10.1371/journal.pone.0119035) (PMID:25746728) (PMCID:PMC4352086)

Robinson, M., Geue, C. , Lewsey, J. , Mackay, D. , McCartney, G., Curnock, E. and Beeston, C. (2014) Evaluating the impact of the Alcohol Act on off-trade alcohol sales: a natural experiment in Scotland. Addiction, 109(12), pp. 2035-2043. (doi: 10.1111/add.12701)

Geue, C. , Briggs, A. , Lewsey, J. and Lorgelly, P. (2014) Population ageing and healthcare expenditure projections: new evidence from a time to death approach. European Journal of Health Economics, 15(5), pp. 885-896. (doi: 10.1007/s10198-013-0543-7)

Robinson, M., Geue, C. , Lewsey, J., Mackay, D. , McCartney, G., Curnock, E. and Beeston, C. (2013) Investigation of the effect of a multi-buy discount ban on off-trade alcohol sales: a natural experiment in Scotland. Lancet, 382(Sup3), S17. (doi: 10.1016/S0140-6736(13)62442-3)

van de Luijtgaarden, M. W. M. et al. (2013) Global differences in dialysis modality mix: the role of patient characteristics, macroeconomics and renal service indicators. Nephrology Dialysis Transplantation, 28(5), pp. 1264-1275. (doi: 10.1093/ndt/gft053)

Kramer, A., Stel, V.S., Caskey, F.J., Stengel, B., Elliott, R.F., Covic, A., Geue, C. , Cusumano, A., MacLeod, A.M. and Jager, K.J. (2012) Exploring the association between macroeconomic indicators and dialysis mortality. Clinical Journal of the American Society of Nephrology, (doi: 10.2215/CJN.10461011)

Geue, C. , Lewsey, J. , Lorgelly, P., Govan, L. , Hart, C. and Briggs, A. (2012) Spoilt for choice: implications of costing hospital episode statistics. Health Economics, 21(10), pp. 1201-1216. (doi: 10.1002/hec.1785)

Caskey, F.J. et al. (2011) Global variation in renal replacement therapy for end-stage renal disease. Nephrology Dialysis Transplantation, 26(8), pp. 2604-2610. (doi: 10.1093/ndt/gfq781)

Caskey, F.J., Stel, V.S., Elliott, R.F., Jager, K.J., Covic, A., Cusumano, A., Geue, C. , Kramer, A., Stengel, B. and MacLeod, A.M. (2010) The EVEREST study: an international collaboration. NDT Plus, 3(1), pp. 28-36. (doi: 10.1093/ndtplus/sfp146)

Geue, C. , Skåtun, D. and Sutton, M. (2009) Economic influences on GP's decisions to provide out-of-hours care. British Journal of General Practice, 59(558), e1-e7. (doi: 10.3399/bjgp09X394806)

Research Reports or Papers

Robinson, M., Geue, C. , Lewsey, J. , Mackay, D. , McCartney, G., Curnock, E. and Beeston, C. (2013) Monitoring and Evaluating Scotland’s Alcohol Strategy: The Impact of the Alcohol Act on Off-Trade Alcohol Sales in Scotland. Project Report. NHS Health Scotland, Edinburgh, UK.

Conference or Workshop Item

Owusu Achiaw, S. , Geue, C. and Grieve, E. (2023) The Role of Universal Health Coverage in Secondary Prevention: A Case Study of Ghana’s National Health Insurance and Early-Onset Hypertension. Diversity in Health Economics, 15th International Health Economics Association World Congress, Cape Town, South Africa, 08-12 Jul 2023.

Rana, D. et al. (2020) Healthcare Costs for Metastatic Castration Resistant Prostate Cancer Patients Treated with Abiraterone or Enzalutamide in the Pre and Post Chemotherapy Setting. EUHEA 2020, Online, 9 July 2020.

Scarborough, M. et al. (2017) Oral versus intravenous antibiotics for the treatment of bone and joint infection (OVIVA): a multicentre randomised controlled trial. 36th Annual Meeting of the European Bone and Joint Infection Society, Nantes, France, 7-9 Sep 2017.

This list was generated on Fri Dec 20 20:04:02 2024 GMT.

Grants

Grants and Awards listed are those received whilst working with the University of Glasgow.

  • New care home admission after hospitalisation - understanding trajectories and predictors using linked health and social care data
    Dunhill Medical Trust
    2020 - 2022
     
  • OAC Evaluation
    Bristol-Myers Squibb
    2019 - 2020
     
  • Addressing uncertainty around the reach and quality of optometrist independent prescribing in Scotland
    Chief Scientist Office
    2018 - 2018
     
  • Incidence and the Economic burden of cardiovascular events in type 2 diabetes mellitus
    Novo Nordisk
    2017 - 2018
     
  • Developing a Scottish type 2 diabetes policy model and piloting a web-based decision aid "dashboard"
    Chief Scientist Office
    2017 - 2019
     
  • What is the impact of large scale implementation of stroke Early Supported Discharge?
    National Institute for Health Research
    2017 - 2020
     
  • The effect of geography and socioeconomic status on health care costs at the end of life: implications for resource allocation and expenditure projections in Scotland
    Chief Scientist Office
    2014 - 2016
     

Supervision

  • Putri, Septiara
    Economic &Return on Investment Model for Prevention Program
  • Tesha, Novatus Apolinary
    Cost-effectiveness of cervical cancer HPV DNA self-testing screening in Low Resource Setting

Completed PhD Supervision:

‘Evaluating stroke rehabilitation provision in Thailand: analysis of real-world data, economic evaluation and value of implementation’ with Wu O (2019-2022); Government funding Thailand. Student: Suthasinee Kumluang

‘Improving the estimation of cost-of-illness in rheumatoid arthritis’ with Wu O, McIntosh E (2017-2021); Government funding Taiwan. Student: Ping Hsuan Hsieh

‘The role of real-world evidence in HTA: A case study of direct oral anticoagulants in the atrial fibrillation population’ with Wu O, Langhorne P (2014-2019); funded by the Farr Institute and the MRC. Student: Giorgio Ciminata

 

Teaching

Co-Director: MSc Health Economics and Health Technology Assessment, University of Glasgow.

Course lead: Real World Data in Healthcare Decision Making, 10-week MSc module and CPD course. University of Glasgow

Course Co-lead: HTA - Policy and Principles, 10-week MSc module and CPD course. University of Glasgow

Recognising Excellence in Teaching Fellow. University of Glasgow, 2018.

Postgraduate Certificate in Academic Practice (PgCAP). University of Glasgow, 2019.


Rsized july 18